Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Arq. bras. med. vet. zootec. (Online) ; 71(2): 647-657, mar.-abr. 2019. tab
Article in English | LILACS, VETINDEX | ID: biblio-1011286

ABSTRACT

Minas artisanal cheese is made from endogenous starter cultures, including lactic acid bacteria (LAB). Some LAB may possess probiotic potential. Thus, this study aimed to evaluate the in vitro probiotic properties of lactobacilli isolated from Minas artisanal cheeses produced in Minas Gerais. Ten samples of lactobacilli, formerly isolated from those cheeses, were submitted to the following assays: antimicrobial susceptibility, tolerance to artificial gastric juice and biliary salts, production of hydrogen peroxide and antagonism against pathogenic and non-pathogenic micro-organisms. Only L. plantarum (C0) was sensitive to all tested antimicrobials, while the other LAB samples were resistant to at least one drug. Six samples were tolerant to artificial gastric juice, and L. brevis (A6) even grew in that medium. Three samples were tolerant to biliary salts. Only L. brevis (E35) produced hydrogen peroxide. Difference (P< 0.05) was observed among the means of inhibition haloes of lactobacilli against Enterococcus faecalis ATCC 19433 and Lactobacillus plantarum C24 in spot-on-the-lawn assay. All samples of lactobacilli inhibited Escherichia coli ATCC 25922, Salmonella enterica var. Typhimurium ATCC 14028 in co-culture antagonism test (P< 0.0001). Most lactobacilli samples showed in vitro probiotic potential. From the tested samples, L. brevis (A6) presented the best results considering all in vitro probiotic tests.(AU)


O queijo minas artesanal é produzido por culturas starters endógenas, incluindo bactérias ácido-láticas (BAL). Algumas BAL podem possuir potencial probiótico. Com isso, este estudo teve como objetivo avaliar as propriedades probióticas in vitro de lactobacilos isolados de queijo minas artesanal produzido no estado de Minas Gerais. Dez amostras de lactobacilos, previamente isoladas desses queijos, foram submetidas aos seguintes testes: susceptibilidade aos antimicrobianos, tolerância ao suco gástrico artificial e aos sais biliares, produção de peróxido de hidrogênio e antagonismo contra micro-organismos patogênicos e não patogênicos. Apenas L. plantarum (C0) foi sensível a todos os antimicrobianos testados, enquanto as outras amostras de BAL foram resistentes a, pelo menos, uma droga testada. Seis amostras foram tolerantes ao suco gástrico artificial, e L. brevis (A6) apresentou crescimento nesse meio. Três amostras foram tolerantes aos sais biliares. Apenas L. brevis (E35) produziu peróxido de hidrogênio. Diferença (P<0,05) foi observada entre as médias dos halos de inibição de lactobacilos contra Enterococcus faecalis ATCC 19433 e Lactobacillus plantarum C24 no teste do spot-on-the-lawn. Todas as amostras de lactobacilos inibiram Escherichia coli ATCC 25922, Salmonella enterica var. Typhimurium ATCC 14028 no teste de antagonismo em cocultura (P<0,0001). A maioria das amostras de lactobacilos apresentou potencial probiótico in vitro. Com base nas amostras testadas, L. brevis (A6) apresentou os melhores resultados, considerando-se todos os testes probióticos in vitro.(AU)


Subject(s)
Cheese/microbiology , Probiotics/isolation & purification , Lactobacillus/isolation & purification , Antibiosis
2.
Arq. bras. med. vet. zootec. (Online) ; 69(6): 1645-1652, nov.-dez. 2017. ilus, tab, graf
Article in English | LILACS, VETINDEX | ID: biblio-911101

ABSTRACT

This study aimed to isolate native lactic acid bacteria of yellow tail lambari (Astyanax bimaculatus) and evaluate their effect on host microbiota and gut morphology, as well as survival after experimental challenge. The isolated bacterial strains were evaluated for their inhibition against pathogenic bacterial strains in vitro, and the strain with highest inhibitory ability was molecularly identified as Lactobacillus spp. For in vivo testing, eighty fish were distributed in ten tanks equipped with a recirculation system. The experimental units were divided into two treatments: fish fed with Lactobacillus spp. supplement and fish fed an unsupplemented diet (control). After 30 days, guts from three fish from each experimental unit were pooled for microbiological and histological analysis. The other five fish were inoculated with 2.1x104CFU.mL-1 of Aeromonas hydrophila to evaluate survival after 24h. Lambaris fed with the probiotic diet had a lower count of Vibrios spp., Pseudomonas spp. and Staphylococcus spp., and a higher count of lactic acid bacteria compared to control treatment, as well as, increased length, width and perimeter of intestinal villi, as well as higher survival rate (16.2%) after experimental challenge compared to the unsupplemented group. The results show that the Lactobacillus spp. used has effect probiotic for yellow tail lambari.(AU)


Este estudo objetivou isolar bactéria ácido-láctica nativa do lambari-do-rabo-amarelo (Astyanax bimaculatus) e seu efeito na microbiota e morfologia do trato digestório do hospedeiro, assim como a sobrevivência após um desafio experimental. As bactérias isoladas foram avaliadas quanto a suas inibições in vitro contra bactérias patogênicas; a cepa com maior capacidade de inibição foi identificada como Lactobacillus spp. Para o teste in vivo, 80 peixes foram distribuídos em 10 tanques equipados com sistema de recirculação. As unidades experimentais foram divididas em dois tratamentos: peixes alimentados com Lactobacillus spp. suplementado e peixes alimentados com dieta não suplementada (controle). Após 30 dias, foram coletados o trato intestinal de três peixes, por unidade experimental, para análises microbiológicas e histológicas. Outros cinco peixes foram inoculados com 2,1x104UFCmL-1 de Aeromonas hydrophila para se avaliar a sobrevivência após 24h. Lambaris alimentados com probiótico apresentaram menor contagem de Vibrios spp., Pseudomonas spp. e Staphylococcus spp., e maior de bactérias ácido-lácticas quando comparados com o tratamento controle, assim como aumento do comprimento, da largura e do perímetro das vilosidades intestinais e maior taxa de sobrevivência (16,2%,) após desafio experimental, em comparação com o grupo sem suplementação. Os resultados mostram que o Lactobacillus spp. possui efeito probiótico para o lambari-do-rabo-amarelo.(AU)


Subject(s)
Animals , Characidae/microbiology , Gastrointestinal Microbiome , Lactobacillus , Probiotics/isolation & purification
3.
Braz. j. microbiol ; 48(4): 730-739, Oct.-Dec. 2017. tab, graf
Article in English | LILACS | ID: biblio-889160

ABSTRACT

ABSTRACT Objective To screen for and characterize lactic acid bacteria strains with the ability to produce fermented milk and reduce cholesterol levels. Methods The strains were isolated from traditional fermented milk in China. In vitro and in vivo evaluation of cholesterol-reduction were used to identify and verify strains of interest. Characteristics were analyzed using spectrophotometry and plate counting assays. Results The isolate HLX37 consistently produced fermented milk with strong cholesterol-reducing properties was identified as Lactobacillus plantarum (accession number: KR105940) and was thus selected for further study. The cholesterol reduction by strain HLX37 was 45.84%. The isolates were acid-tolerant at pH 2.5 and bile-tolerant at 0.5% (w/v) in simulated gastric juice (pH 2.5) for 2 h and in simulated intestinal fluid (pH 8.0) for 3 h. The auto-aggregation rate increased to 87.74% after 24 h, while the co-aggregation with Escherichia coli DH5 was 27.76%. Strain HLX37 was intrinsically resistant to antibiotics such as penicillin, tobramycin, kanamycin, streptomycin, vancomycin and amikacin. Compared with rats in the model hyperlipidemia group, the total cholesterol content in the serum and the liver as well as the atherogenic index of rats in the viable fermented milk group significantly decreased by 23.33%, 32.37% and 40.23%, respectively. Fewer fat vacuoles and other lesions in liver tissue were present in both the inactivated and viable fermented milk groups compared to the model group. Conclusion These studies indicate that strain HLX37 of L. plantarum demonstrates probiotic potential, potential for use as a candidate for commercial use for promoting health.


Subject(s)
Animals , Male , Cattle , Rats , Cholesterol/metabolism , Milk/microbiology , Lactobacillus plantarum/metabolism , Bile Acids and Salts/pharmacology , China , Rats, Sprague-Dawley , Probiotics/isolation & purification , Probiotics/metabolism , Cultured Milk Products/microbiology , Lactobacillus plantarum/isolation & purification , Lactobacillus plantarum/drug effects , Lactobacillus plantarum/genetics , Fermentation , Anti-Bacterial Agents/pharmacology
4.
Rev. argent. microbiol ; 48(3): 236-244, set. 2016. ilus, graf, tab
Article in English | LILACS | ID: biblio-843168

ABSTRACT

Lactic acid bacteria are known for their biotechnological potential. In various regions of Ecuador numerous indigenous biological resources are largely undocumented. In this study, we evaluated the potential probiotic characteristics and antagonistic in vitro properties of some lactic acid bacteria from native niches of the subtropical rain forests of Ecuador. These isolates were identified according to their morphological properties, standard API50CH fermentation profile and RAPD-DNA polymorphism pattern. The selected isolates were further evaluated for their probiotic potential. The isolates grew at 15 °C and 45 °C, survived at a pH ranging from 2.5 to 4.5 in the presence of 0.3% bile (>90%) and grew under sodium chloride conditions. All selected isolates were sensitive to ampicillin, amoxicillin and cefuroxime and some showed resistance to gentamicin, kanamycin and tetracycline. Moreover, the agar well diffusion assay showed that the supernatant of each strain at pH 3.0 and pH 4.0, but not at pH 7.0 exhibited increased antimicrobial activity (inhibition zone >15 mm) against two foodborne pathogens, Escherichia coli and Salmonella spp. To our knowledge, this is the first report describing the antagonistic activity against two foodborne pathogens and the probiotic in vitro potential of lactic acid bacteria isolated from native biota of Ecuador.


Las bacterias ácido lácticas (BAL) son conocidas por su potencial biotecnológico. En diversas regiones del Ecuador existen recursos biológicos nativos, que en su mayoría no han sido documentados. En este estudio se evaluaron in vitro las posibles características probióticas y antagónicas de algunas BAL aisladas de nichos nativos de la selva subtropical. Estas cepas se clasificaron en función de sus propiedades morfológicas, el perfil estándar de fermentación API50CH y los patrones de polimorfismo RAPD-ADN. Diez microorganismos fueron seleccionados y se probó su potencial probiótico. Todas las bacterias crecieron a 15 °C y 45 °C, sobrevivieron en el rango de pH ácido de 2,5 a 4,5 en presencia de 0,3% de bilis (> 90%), mostraron tolerancia a los tratamientos en cloruro de sodio y diferentes perfiles de sensibilidad a antibióticos. Todas las cepas fueron sensibles a ampicilina, amoxicilina y cefuroxima, y algunas fueron resistentes a gentamicina, kanamicina y tetraciclina. Por otra parte, el ensayo de pruebas de difusión en agar mostró que el sobrenadande de cada cepa cultivada a pH 3,0 y pH 4,0, pero no a pH 7,0, presentó elevada actividad antimicrobiana (zona de inhibición > 15 mm) frente a 2 agentes patógenos alimentarios, Escherichia coli y Salmonella spp. Este estudio describe por primera vez la actividad antagonista frente a patógenos de origen alimentario y el potencial probiótico in vitro de BAL aisladas de nichos ecológicos nativos del Ecuador.


Subject(s)
Bacteria/isolation & purification , Probiotics/pharmacokinetics , Anti-Bacterial Agents/analysis , In Vitro Techniques/methods , Probiotics/isolation & purification
5.
Braz. j. microbiol ; 44(3): 685-691, July-Sept. 2013. ilus, graf, tab
Article in English | LILACS | ID: lil-699785

ABSTRACT

A strain of lactic acid bacteria, Leuconostoc lactis, was isolated from the intestinal tract of black porgy, Sparus macrocephalus, and identified by conventional biochemical characteristics and 16S rDNA gene sequence analysis. The isolated strain had the ability of bile tolerance and resistance to low pH, and survived well in the trypsinase and pepsin solution. But the highly concentrated dose of trypsinase and pepsin affect the viability of the isolated strain. The isolate was resistant to several antibiotics, including Cephalothin, Ceftriaxone, Imipenem and Tobramycin. The isolate could autoaggregate itself and coaggregate with other bacteria in vitro. The autoaggregation percentage increased to 23.29% after 20 h of incubation. The percentage of coaggregation were respectively 31.21%, 29.44%, 10.74%, 16.49%, 24.36%, 24.41% and 20.99% for Vibrio parahaemolyticus, Listeria monocytogenes, Escherichia coli O157, Salmonella typhimurium, Shigella, Staphylococcus aureus and Proteusbacillus vulgaris after 20 h incubation of a mixed suspension. The supernatant of the strain inhibited the growth of several pathogens, such as V.parahaemolyticus, Vibrio harveyi, Vibrio alginolyticus, Staphylococcus aureus, Escherichia coli O157, Salmonella typhimurium, Bacillus subtilis, Proteusbacillus vulgaris and Shigella. These results indicated that the isolate, Leuconostoc lactis, might be an attractive candidate for perspectival strain for probiotics in marine aquaculture.


Subject(s)
Animals , Intestines/microbiology , Leuconostoc/isolation & purification , Leuconostoc/physiology , Perciformes/microbiology , Probiotics/isolation & purification , Antibiosis , Anti-Bacterial Agents/pharmacology , Bacterial Adhesion , Bacterial Typing Techniques , Bile Acids and Salts/toxicity , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Hydrogen-Ion Concentration , Leuconostoc/classification , Leuconostoc/genetics , Microbial Viability/drug effects , Phylogeny , Pepsin A/metabolism , /genetics , Sequence Analysis, DNA , Trypsin/metabolism
6.
Braz. j. microbiol ; 44(1): 43-49, 2013. ilus, tab
Article in English | LILACS | ID: lil-676885

ABSTRACT

Meat and particularly ground beef is frequently associated with Food Poisoning episodes and breeches in Food Safety. The main goal of this research was to evaluate the bactericide effect of the probiotic Enterococcus faecalis CECT7121, against different pathogens as: Escherichia coli O157:H7, Staphylococcus aureus, Clostridium perfringens and Listeria monocytogenes, inoculated in ground beef meat. Three studies were performed to evaluate the inhibition of E. faecalis CECT7121 on ground beef meat samples inoculated with pathogens: Study I: Samples (100 g meat) were inoculated with pathogens (10³ CFU/g)) and E. faecalis CECT7121 (10(4) CFU/g) simultaneously. Study II: Samples were inoculated with E. faecalis CECT7121 24 h before the pathogens. Study III: E. faecalis CECT7121were inoculated 24 h after pathogens. The viable counts were performed at 0, 24, 48 and 72 h post-inoculation. The simultaneous inoculation of E. faecalis CECT7121 with E. coli O157:H7 strains resulted in the absence of viable counts of bacteria at 72 h post-treatment. However, when the probiotic was added 24 h before and 24 h after the pathogen E. coli O157:H7, viable cells were not detected at 24 h and 48 h post-treatment, respectively. Consistently, neither S. aureus nor Cl. perfringens viable bacteria were detected at 48 h in whole assays when inoculated with E. faecalis CECT7121. The same trend than described before was obtained after applying the 3 models assayed for L. monocytogenes. The current assays demonstrated the bactericide activity of E. faecalis CECT7121 strain on bacterial pathogens in ground beef meat.


Subject(s)
Humans , Animals , Child , Cattle , Bacterial Infections , Meat/analysis , Enterococcus faecalis/isolation & purification , Food Preservation , Probiotics/isolation & purification , Meat Products/analysis , Cattle , Food Microbiology , Food Samples , Methods , Virulence
7.
Braz. j. microbiol ; 43(1): 418-428, Jan.-Mar. 2012. ilus, tab
Article in English | LILACS | ID: lil-622832

ABSTRACT

In this study, we checked lactobacilli strains of human origin for their potential as probiotic. Samples were collected from oral mucosa of 16 healthy individuals, out of which twenty isolates were obtained and two of them were selected and identified as Lactobacillus plantarum (G1) and L. casei (G3). Both isolates exhibited antagonistic action towards pathogenic microorganisms such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Salmonella abony, and Clostridium sporogenes, but not on the growth of Candida albicans. The bacteriocin activity against Staphylococcus aureus ATCC 6358-P was shown only by L. plantarum G1. Moreover, the isolates G1 and G3 showed good viability in the acid gastric environment and in the gut environment containing bovine bile salts. The viability of G1 and G3 isolates in the gastrointestinal tract, and the adhesion to the intestinal mucosa were also confirmed in vivo. The biochemical tests of blood samples revealed lower levels of serum triglycerides and cholesterol, as well as reduced activity of alkaline phosphatase in all lactobacilli-treated Wistar rats, compared to control ones. No toxicity for NMRI Ham mice was observed. According to our experimental results, these findings imply that L. plantarum G1 and L. casei G3 could be characterized as potential probiotics.


Subject(s)
Humans , Anti-Bacterial Agents , Bacterial Adhesion , Blood Bactericidal Activity , Gastrointestinal Tract , Lactobacillus/isolation & purification , Microbial Viability , Mouth Mucosa , Probiotics/isolation & purification , Food Microbiology , Methods , Methods
8.
Braz. j. microbiol ; 42(1): 147-157, Jan.-Mar. 2011. ilus, tab
Article in English | LILACS | ID: lil-571386

ABSTRACT

The Lactobacillus acidophilus group is a phylogenetically distinct group of closely related lactobacilli. Members of this group are considered to have probiotic properties and occupy different environmental niches. Bacteria generally sense and respond to environmental changes through two component systems (TCSs) which consist of a histidine protein kinase (HPK) and its cognate response regulator (RR). With the use of in silico techniques, the five completely sequenced L. acidophilus group genomes were scanned in order to predict TCSs. Five to nine putative TCSs encoding genes were detected in individual genomes of the L. acidophilus group. The L. acidophilus group HPKs and RRs were classified into subfamilies using the Grebe and Stock classification method. Putative TCSs were analyzed with respect to conserved domains to predict biological functions. Putative biological functions were predicted for the L. acidophilus group HPKs and RRs by comparing them with those of other microorganisms. Some of TCSs were putatively involved in a wide variety of functions which are related with probiotic ability, including tolerance to acid and bile, production of antimicrobial peptides, resistibility to the glycopeptide antibiotic vancomycin, and oxidative condition.


Subject(s)
Anti-Bacterial Agents , Base Sequence , DNA-Activated Protein Kinase , Glycopeptides , Histidine , Lactobacillus acidophilus/genetics , Lactobacillus acidophilus/isolation & purification , Peptides , Probiotics/isolation & purification , Signal Transduction , Computational Biology , Enzyme Activation , Methods , Methods
9.
Braz. j. microbiol ; 41(1): 6-14, Jan.-Mar. 2010. ilus, graf, tab
Article in English | LILACS | ID: lil-531726

ABSTRACT

Urogenital infections affect millions of people every year worldwide. The treatment of these diseases usually requires the use of antimicrobial agents, and more recently, the use of probiotic lactic acid bacteria (LAB) cultures for the management of vaginal infections has been extensively studied. In this work, 11 vaginal lactobacilli isolates, previously obtained from healthy patients, were studied to screen microorganisms with probiotic properties against Candida spp. The LAB were tested for their ability of auto-aggregation, coaggregation with C. albicans, C. glabrata, C. krusei, and C. tropicalis, adhesion to Caco-2 epithelial cells and production of lactic acid and hydrogen peroxide (H2O2). All lactobacilli isolates tested were able to auto-aggregate (ranging from 25.3 percent to 75.4 percent assessed at 4 hours of incubation) and to co-aggregate with the four Candida species into different degrees; among them L. crispatus showed the highest scores of coaggregation. The highest amount of lactic acid was produced by L. salivarius (13.9 g/l), followed by L. johnsonii (6.5 g/l), L. acidophilus (5.5 g/l), and L. jensenii (5.4 g/l). All isolates produced H2O2 , but the highest levels (3 -10 mg/l) were observed for L. acidophilus, L. crispatus, L. gasseri, L. johnsonii, and L. vaginalis. Only L. agilis, L. jensenii, L. johnsonii and L. ruminus were able to adhere to epithelial Caco-2 cells. Among the isolates evaluated, L agilis, L. jensenii, L. johnsonii, and L. ruminus exhibited simultaneously several desirable properties as potential probiotic strains justifying future studies to evaluate their technological properties in different pharmaceutical preparations for human use.


Subject(s)
Humans , Anti-Bacterial Agents/isolation & purification , Candida , Culture Media , Lactobacillus/isolation & purification , Probiotics/isolation & purification , Urinary Tract Infections , Diagnostic Techniques and Procedures , Methods
10.
Braz. j. microbiol ; 41(1): 107-115, Jan.-Mar. 2010. graf, tab
Article in English | LILACS | ID: lil-531741

ABSTRACT

To evaluate the effect of two bacterial strains isolated from Artemia cysts and yeast (Candida utilis) on the survival, growth and total biomass production of its larvae, challenge tests were performed with Candida utilis, Pseudomonas stutzeri and Pasteurella haemolityca. In addition, a pathogenic strain of Vibrio alginolyticus was tested for comparative purposes. Pseudomonas stutzeri and Candida utilis have no impact on survival, but enhance growth and total biomass production of the larvae. However, we noted that Pasteurella haemolityca affect negatively Artemia larvae. The adhesion and antagonism assay demonstrates that Candida utilis and Pseudomonas stutzeri are fairly adherent and play an important role in the enhancement of the protection of Artemia culture against pathogens. On the basis of these results, it's suggested that it's possible to use Candida utilis and Pseudomonas stutzeri, potential candidates, as probiotic for the culture of Artemia larvae.


Subject(s)
Artemia , Cell Survival , Candida/growth & development , Candida/isolation & purification , Yeasts/growth & development , Yeasts/isolation & purification , Probiotics/isolation & purification , Pseudomonas stutzeri/isolation & purification , Food Samples , Methods , Methods , Virulence
11.
Rev. MVZ Córdoba ; 13(1): 1157-1169, ene.-abr. 2008. tab, graf
Article in Spanish | LILACS | ID: lil-498565

ABSTRACT

Objetivo. Evaluar preliminarmente in vitro algunas propiedades probióticas de dos cepas nativas de S.cerevisiae. Materiales y métodos. Las cepas fueron utilizadas en ensayos de tolerancia a sales biliares, pH, temperatura, adherencia a Salmonella spp., E.coli y Shigella spp., y antagonismo. Se realizó un diseño factorial 33 x 3, con tres niveles de cada factor (cepa, pH y concentración inicial de sustrato) por triplicado, para establecer las condiciones de cultivo de cada cepa. Como control se empleó una cepa comercial (B). La cepa seleccionada se empleó para la producción en biorreactor de 2L; la biomasa fue sometida a secado por temperatura; al producto resultante se le determinó concentración de N2 y la viabilidad celular. Resultados. La cepa A (obtenida de caña de azúcar), toleró pH 3 ± 0.2, 0.3% (p/v) de sales biliares y 42oC. El ANOVA del diseño factorial reportó diferencias significativas entre los 27 ensayos (p≤0.05), el análisis de superficies reportó que la interacción entre los factores cepa y Sustrato (S0) son significativos, sugiriendo para la optimización la cepa A y concentraciones crecientes de S0. Los resultados se reprodujeron en biorreactor con mx 0.31h-1, td 2.18h y Y(x/s) 0.126g/g; la biomasa seca obtenida fue viable y reportó entre 6.3 y 6.9% N2/g. Conclusiones. Se identificaron levaduras nativas con propiedades probióticas como tolerancia a pH, sales biliares, temperatura y adherencia a Salmonella spp., E.coli y Shigella spp.


Subject(s)
In Vitro Techniques , Probiotics , Saccharomyces cerevisiae , Probiotics/analysis , Probiotics/isolation & purification , Saccharomyces cerevisiae/classification , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/pathogenicity , Saccharomyces cerevisiae/chemistry
12.
Braz. j. microbiol ; 39(1): 50-55, Jan.-Mar. 2008. tab
Article in English | LILACS | ID: lil-480673

ABSTRACT

Probiotics are viable defined microorganisms (bacteria or yeasts) that exert a beneficial effect on the health of the host when ingested in adequate amounts. Screening for such biotherapeutic agents is commonly performed by in vitro assays simulating gastrointestinal environment to determine the ability to survive in the digestive tract. In the present study, the possibility of extrapolation of data obtained in in vitro assays to in vivo conditions was studied using five Saccharomyces cerevisiae strains isolated from Brazilian Atlantic rain forest. Trehalose contents and survival after exposure to a combination of physiological stresses generally found in the gastrointestinal tract of humans were determined for the five yeasts and compared to the behavior of Saccharomyces boulardii, a well-known probiotic. The results were completed with the colonization capacity of the gastrointestinal tract of gnotobiotic mice by these yeast strains. Some results obtained by in vitro assays are not confirmed by in vivo experiments, indicating that the extrapolation cannot be always done.


Probióticos são definidos como microrganismos (bactérias e leveduras) que exercem um efeito benéfico na saúde do hospedeiro quando ingeridos em quantidades adequadas. A seleção desses agentes bioterapêuticos normalmente é feita por testes in vitro simulando o ambiente gastrointestinal que determina a capacidade de sobrevivência no trato digestivo. Neste trabalho, a possibilidade de extrapolação dos dados obtidos nos testes in vitro para as condições in vivo foi estudada utilizando cinco linhagens de Saccharomyces cerevisiae isoladas da floresta Atlântica brasileira. O conteúdo de trealose e a sobrevivência após a exposição a diversos estresses fisiológicos geralmente encontrados no trato gastrointestinal de humanos foram determinados para as cinco linhagens e os resultados comparados com a Saccharomyces boulardii, um probiótico conhecido. Esses resultados foram completados com a capacidade de colonização do trato gastrointestinal de camundongos gnotobióticos pelas leveduras. Pelos resultados obtidos, concluimos que os testes in vitro não são confirmados pelos ensaios in vivo, indicando que essa extrapolação não pode sempre ser feita.


Subject(s)
Animals , In Vitro Techniques , Mycoses , Probiotics/isolation & purification , Saccharomyces cerevisiae/isolation & purification , Saccharomyces/isolation & purification , Diagnostic Techniques and Procedures , Trehalose/analysis , Yeasts , Methods , Stress, Mechanical
13.
Nutrire Rev. Soc. Bras. Aliment. Nutr ; 32(3): 103-122, 2007. ilus
Article in Portuguese | LILACS | ID: biblio-882126

ABSTRACT

The use of probiotic cultures as multifunctional health and welfare promoting agents has greatly increased with the publication of an ever-increasing number of scientific studies attesting their therapeutic efficacy. At the same time, a new approach has been developed for the functioning of the human intestinal tract, which is no longer seen as merely a digestive tube, but has become increasingly recognized as one of the main targets of immune responses. This review explores the main health benefits associated with the regular consumption of food products containing recognized probiotic strains. There is a substantial body of scientific evidence supporting the following health benefits of probiotics: balance of intestinal microbiota, relief of constipation, immunomodulation, prevention of colon cancer, improvement of lactose digestion, prevention of atopic eczema, suppressive activity against gastrointestinal pathogens (Helicobacter pylori, Listeria monocytogenes, Salmonella typhimurium, Giardia intestinalis), prevention of diseases of the female urogenital tract, in addition to other intestinal disorders (diarrhea, Crohn's disease, irritable bowel syndrome, ulcerative colitis, pouchitis) and diseases of other body systems


El empleo de cultivos probióticos como agentes multifuncionales promotores de salud y bienestar ha aumentado en virtud de los estudios científicos comprobando su eficacia terapéutica. Paralelamente, existe un nuevo enfoque sobre la función del intestino humano, que dejó de ser visto solamente como un tubo digestivo para ser reconocido como el principal centro de las respuestas in munitarias. Esta revisión aborda los principales beneficios a la salud proporcionados por el consumo regular de productos que contienen linajes microbianas reconocidamente probióticas. Entre las evidencias científicas de promoción de la salud se destacan: equilibrio dela microbiota intestinal, mejora del estreñimiento, inmunomodulación, prevención del cáncer de colón, mejor digestión de la lactosa, prevención de eccemas atópicos, actividad supresora contrapatógenos gastrointestinales (Helicobacter pylori, Listeria monocytogenes, Salmonella typhimurium, Giardia intestinalis), prevención de las patologias del tracto urogenital femenino y de patologias intestinales (diarreas, Enfermedad de Crohn, Síndrome del intestino irritable, colitis ulcerosa), entre otras


O emprego de culturas probióticas como agentes multifuncionais promotores de saúde e bem-estar tem aumentado em virtude dos estudos científicos comprovando a sua eficácia terapêutica. Paralelamente, existe um novo enfoque sobre a função do intestino humano, que deixou de ser visto apenas como um tubo digestivo para ser reconhecido como o principal alvo das respostas imunitárias. Esta revisão aborda os principais benefícios à saúde conferidos pelo consumo regular de produtos que contenham linhagens microbianas reconhecidamente probióticas. Dentre as evidências científicas de que promove a saúde são destacados: equilíbrio da microbiota intestinal, alívio da constipação, imunomodulação, prevenção do câncer de cólon, melhor digestão da lactose, prevenção de eczemas atópicos, atividade supressiva contra patógenos gastrintestinais (Helicobacter pylori, Listeria monocytogenes, Salmonella typhimurium, Giardia intestinalis), prevenção de patologias do trato urogenital feminino, bem como desordens intestinais (diarreia, doença de Crohn, Síndrome do Intestino Irritável, Retrocolite Ulcerativa, bolsite), entre outros


Subject(s)
Humans , Male , Female , Probiotics/administration & dosage , Probiotics/analysis , Probiotics/therapeutic use , Functional Food , Gastrointestinal Microbiome , Probiotics/isolation & purification
14.
Braz. j. microbiol ; 31(4): 303-307, oct.-dec. 2000. tab, graf
Article in English, Portuguese | LILACS | ID: lil-299829

ABSTRACT

Studies were carried out to isolate and identify microorganisms for probiotic use for chickens. Selection of strains included various criteria such as agreement with bio-safety aspects, viability during storage, tolerance to low pH/ gastric juice, bile, and antimicrobial activity. The strains were isolated from the crop, proventriculus, gizzard, ileum and caeca of chicken. Decimal dilution of the contents of these segments were mixed with MRS medium and incubated for 48 h at 37ºC under anaerobiosis. The identity of the culture was based on characteristics of lactobacilli as presented in the Bergey's Manual of Determinative Bacteriology, carrying out bacterioscopy (morphology), Gram stain, growth at 15 and 45ºC, and fermentation of different carbon sources. Based on these criteria, Lactobacillus fermentum LPB was identified and tested for probiotic use for chickens. The isolate was evaluated for poultry feeds supplement. The results showed that in comparison to the presence and effects of antibiotics, L. fermentum LPB implantation resulted in a similar effects as that of antibiotics manifested by feed efficiency in growth of chicks.


Subject(s)
Animals , Poultry/physiology , Poultry/microbiology , In Vitro Techniques , Lactobacillus , Probiotics/analysis , Probiotics/isolation & purification , Staining and Labeling/methods , Culture Media
15.
Rev. chil. nutr ; 26(1): 20-34, abr. 1999. tab, graf
Article in Spanish | LILACS | ID: lil-245406

ABSTRACT

Los probióticos son microorganismos, bacterias o levaduras, que después de haber sido ingeridos por el individuo pueden transitar vivos a lo largo del tubo digestivo y ejercer acciones específicas, beneficiosas para su salud. Las bacterias lácticas, en particular, se han usados empíricamente desde hace siglos en forma de yogurt, kefir o leche cultivada, para prevenir o/y curar numerosas patologías gastrointestinales, por lo cual están asociadas, en la opinión pública, con la imagen de "alimentos sanos". Durante la última década, se han efectuado numerosos estudios tanto clínicos como básicos, con el fin de comprobar el real impacto de los probióticos sobre la salud. En la actualidad está plenamente confirmado que la ingestión de lactobacilos mejora la tolerancia a la lactosa en los individuos hipolactásicos, y que limita la colonización del intestino por patógenos, lo cual se puede traducir a nivel clínico por un menor riesgo de desarrollar diarrea. Otros estudios sugieren un papel para los probióticos en la estimulación del sistema inmune del individuo, en la reducción de actividades enzimáticas implicadas en el desarrollo de lesiones malignas a nivel colónico y posiblemente en la disminución de la colesterolemia. A pesar de los numerosos resultados ya obtenidos, es necesario seguir explorando las propiedades funcionales de los probióticos, a fin de optimizar su uso tanto en el campo nutricional como terapéutico


Subject(s)
Humans , Bacteria, Anaerobic , Digestive System/microbiology , Probiotics/pharmacology , Bifidobacterium , Cholesterol/blood , Dairy Products , Feces/microbiology , Gastrointestinal Diseases , Lactobacillus , Lactose Intolerance , Probiotics/isolation & purification , Probiotics/therapeutic use , Yogurt/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL